BCLI

BRAINSTORM CELL THERAPUTC

Delisted

BCLI was delisted on the 17th of July, 2025.

53 hedge funds and large institutions have $928K invested in BRAINSTORM CELL THERAPUTC in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

83% less call options, than puts

Call options by funds: $149K | Put options by funds: $888K

93% less capital invested

Capital invested by funds: $14.1M → $928K (-$13.1M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$149K
Puts
$888K
Net Calls
Net Calls Change

Top Buyers

1 +$40.7K
2 +$40.5K
3 +$19.4K
4
TSS
Two Sigma Securities
New York
+$8.06K
5
Millennium Management
Millennium Management
New York
+$7.58K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$285K
2
$93.5K
3
$71K
4
$62.2K
5
$41K
6
$40.5K
7
$35.1K
8
$29K
9
$27.6K
10
$27.3K
11
$19.9K
12
$19.4K
13
$19.2K
14
$18.1K
15
$15.4K
16
$13.1K
17
$11K
18
$9K
19
$8.29K
20
$8.08K
21
$8.06K
22
$7.81K
23
$6.12K
24
$6.12K
25
$5.31K